|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
13,870,000 |
Market
Cap: |
450.08(M) |
Last
Volume: |
50,046 |
Avg
Vol: |
64,913 |
52
Week Range: |
$17.67 - $38.49 |
|
Level
I Sector: |
Basic Materials |
Level
II Sector: |
Chemicals |
Level
III Sector: |
Specialty Chemicals |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Surmodics is a provider of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments are: Medical Device, which develops and manufactures vascular intervention medical device products and is engaged in Co.'s proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, or drug-delivery capabilities to medical devices and delivery systems; and IVD, which manufactures and sells components for IVD immunoassay and molecular tests within the diagnostic, biomedical research, and life science markets.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
9,872 |
Total Sell Value |
$0 |
$0 |
$0 |
$335,339 |
Total People Sold |
0 |
0 |
0 |
3 |
Total Sell Transactions |
0 |
0 |
0 |
3 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Olson Charles W |
Senior VP & GM, Med Dev |
|
2016-12-22 |
4 |
AS |
$26.00 |
$31,226 |
D/D |
(1,201) |
27,386 |
|
- |
|
Olson Charles W |
Senior VP & GM, Med Dev |
|
2016-12-08 |
4 |
AS |
$26.02 |
$96,243 |
D/D |
(3,699) |
28,587 |
|
- |
|
Stich Joseph J. |
VP, Bus Ops & GM, IVD |
|
2016-12-05 |
4 |
AS |
$23.97 |
$23,966 |
D/D |
(1,000) |
42,362 |
|
- |
|
Phillips Bryan K |
SVP, Gen Counsel & Secretary |
|
2016-12-02 |
4 |
AS |
$23.90 |
$30,216 |
D/D |
(1,264) |
30,434 |
|
- |
|
Arens Timothy J. |
VP-Corporate Dev. and Strategy |
|
2016-11-30 |
4/A |
D |
$23.95 |
$39,302 |
D/D |
(1,641) |
24,665 |
|
- |
|
Sutton Gregg S |
VP of Research and Development |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,713 |
3,477 |
|
- |
|
Stich Joseph J. |
VP, Bus Ops & GM, IVD |
|
2016-11-30 |
4 |
D |
$23.95 |
$56,354 |
D/D |
(2,353) |
43,362 |
|
- |
|
Stich Joseph J. |
VP, Bus Ops & GM, IVD |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,594 |
45,715 |
|
- |
|
Phillips Bryan K |
SVP, Gen Counsel & Secretary |
|
2016-11-30 |
4 |
D |
$23.95 |
$56,354 |
D/D |
(2,353) |
31,698 |
|
- |
|
Phillips Bryan K |
SVP, Gen Counsel & Secretary |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,594 |
34,051 |
|
- |
|
Olson Charles W |
Senior VP & GM, Med Dev |
|
2016-11-30 |
4 |
D |
$23.95 |
$56,354 |
D/D |
(2,353) |
32,286 |
|
- |
|
Olson Charles W |
Senior VP & GM, Med Dev |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,594 |
34,639 |
|
- |
|
Lafrence Andrew D. C. |
VP of Finance & CFO |
|
2016-11-30 |
4 |
D |
$23.95 |
$56,354 |
D/D |
(2,353) |
12,160 |
|
- |
|
Lafrence Andrew D. C. |
VP of Finance & CFO |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,594 |
14,176 |
|
- |
|
Maharaj Gary R |
President & CEO |
|
2016-11-30 |
4 |
D |
$23.95 |
$162,788 |
D/D |
(6,797) |
144,608 |
|
- |
|
Maharaj Gary R |
President & CEO |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
21,198 |
151,405 |
|
- |
|
Arens Timothy J. |
VP-Corporate Dev. and Strategy |
|
2016-11-30 |
4 |
D |
$23.95 |
$56,354 |
D/D |
(2,353) |
23,953 |
|
- |
|
Arens Timothy J. |
VP-Corporate Dev. and Strategy |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,594 |
26,306 |
|
- |
|
Greaney Thomas A. |
VP of Operations |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,713 |
2,713 |
|
- |
|
Olson Charles W |
Senior VP & GM, Med Dev |
|
2016-11-25 |
4 |
AS |
$26.05 |
$5,210 |
D/D |
(200) |
27,045 |
|
- |
|
Olson Charles W |
Senior VP & GM, Med Dev |
|
2016-11-23 |
4 |
AS |
$26.00 |
$7,800 |
D/D |
(300) |
27,245 |
|
- |
|
Maharaj Gary R |
President & CEO |
|
2016-11-07 |
4 |
AS |
$25.22 |
$126,116 |
D/D |
(5,000) |
130,207 |
|
- |
|
Maharaj Gary R |
President & CEO |
|
2016-10-03 |
4 |
AS |
$29.55 |
$147,770 |
D/D |
(5,000) |
135,207 |
|
- |
|
Bedoya Jose H |
Director |
|
2016-09-30 |
4 |
A |
$30.09 |
$11,976 |
D/D |
398 |
15,977 |
|
- |
|
Mccormick Shawn |
Director |
|
2016-09-30 |
4 |
A |
$30.09 |
$11,374 |
D/D |
378 |
2,965 |
|
- |
|
888 Records found
|
|
Page 18 of 36 |
|
|